These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 18676755)

  • 41. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
    Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Significance of K-ras detection in colorectal cancer].
    Xu XM; Zhang GL; Li MW; Wang DY; Lin JJ
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1268-71. PubMed ID: 20646601
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Frequent polymorphism of peroxisome proliferator activated receptor gamma gene in colorectal cancer containing wild-type K-ras gene.
    Tomita S; Kawamata H; Imura J; Omotehara F; Ueda Y; Fujimori T
    Int J Mol Med; 2002 May; 9(5):485-8. PubMed ID: 11956653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Frequency and spectrum of K-RAS codons 12 and 13 mutations in colorectal adenocarcinomas from Taiwan.
    Wu CM; Tang R; Wang JY; Changchien CR; Hsieh LL
    Cancer Genet Cytogenet; 2005 Apr; 158(1):55-60. PubMed ID: 15771905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Laterally spreading type of colorectal adenoma exhibits a unique methylation phenotype and K-ras mutations.
    Hiraoka S; Kato J; Tatsukawa M; Harada K; Fujita H; Morikawa T; Shiraha H; Shiratori Y
    Gastroenterology; 2006 Aug; 131(2):379-89. PubMed ID: 16890591
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.
    Sartori G; Cavazza A; Sgambato A; Marchioni A; Barbieri F; Longo L; Bavieri M; Murer B; Meschiari E; Tamberi S; Cadioli A; Luppi F; Migaldi M; Rossi G
    Am J Clin Pathol; 2009 Apr; 131(4):478-89. PubMed ID: 19289583
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistence of K-ras mutations in plasma after colorectal tumor resection.
    Lindforss U; Zetterquist H; Papadogiannakis N; Olivecrona H
    Anticancer Res; 2005; 25(1B):657-61. PubMed ID: 15816642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. K-ras codon 12 mutation determines the polypoid growth of colorectral cancer.
    Chiang JM; Chou YH; Chou TB
    Cancer Res; 1998 Aug; 58(15):3289-93. PubMed ID: 9699657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutation pattern of K-ras gene in colorectal cancer patients of Kashmir: a report.
    Sameer AS; Chowdhri NA; Abdullah S; Shah ZA; Siddiqi MA
    Indian J Cancer; 2009; 46(3):219-25. PubMed ID: 19574674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC).
    Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ
    Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
    Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity.
    Jakobsen A; Nielsen JN; Gyldenkerne N; Lindeberg J
    J Clin Oncol; 2005 Mar; 23(7):1365-9. PubMed ID: 15735113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differences in K-ras and p53 gene mutations among pancreatic adenocarcinomas associated with regional environmental pollution.
    Soliman AS; Lo AC; Banerjee M; El-Ghawalby N; Khaled HM; Bayoumi S; Seifeldin IA; Abdel-Aziz A; Abbruzzese JL; Greenson JK; Hamilton SR
    Carcinogenesis; 2007 Aug; 28(8):1794-9. PubMed ID: 17575320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The prognostic value of the presence of mutations at the codons 12, 13, 61 of K-ras oncogene in colorectal cancer.
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Anticancer Res; 2000; 20(3A):1695-701. PubMed ID: 10928094
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?
    Marcuello E; Altés A; Menoyo A; Rio ED; Baiget M
    Cancer Chemother Pharmacol; 2006 Jun; 57(6):835-40. PubMed ID: 16187112
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years.
    Alsop K; Mead L; Smith LD; Royce SG; Tesoriero AA; Young JP; Haydon A; Grubb G; Giles GG; Jenkins MA; Hopper JL; Southey MC
    Eur J Cancer; 2006 Jul; 42(10):1357-61. PubMed ID: 16765042
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.
    Albanese I; Scibetta AG; Migliavacca M; Russo A; Bazan V; Tomasino RM; Colomba P; Tagliavia M; La Farina M
    Biochem Biophys Res Commun; 2004 Dec; 325(3):784-91. PubMed ID: 15541358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.
    Wistuba II; Behrens C; Albores-Saavedra J; Delgado R; Lopez F; Gazdar AF
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3615-9. PubMed ID: 14506148
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer.
    Saw RP; Koorey D; Painter D; Gallagher PJ; Solomon MJ
    Br J Surg; 2002 Nov; 89(11):1409-15. PubMed ID: 12390383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.